Archimedes Tech SPAC Partners II Co. (NASDAQ:ATII – Get Free Report) was the recipient of a large growth in short interest in the month of May. As of May 15th, there was short interest totaling 54,969 shares, a growth of 532.8% from the April 30th total of 8,687 shares. Based on an average daily trading volume, of 279,427 shares, the short-interest ratio is currently 0.2 days.
Analyst Ratings Changes
Separately, Weiss Ratings upgraded shares of Archimedes Tech SPAC Partners II from a “sell (d-)” rating to a “sell (d)” rating in a report on Friday, May 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.
Check Out Our Latest Analysis on ATII
Institutional Investors Weigh In On Archimedes Tech SPAC Partners II
Archimedes Tech SPAC Partners II Trading Down 0.6%
Shares of ATII stock opened at $11.26 on Thursday. Archimedes Tech SPAC Partners II has a one year low of $10.09 and a one year high of $11.40. The stock’s 50-day moving average is $10.66.
Archimedes Tech SPAC Partners II (NASDAQ:ATII – Get Free Report) last issued its quarterly earnings data on Thursday, May 14th. The company reported $0.06 earnings per share for the quarter.
Archimedes Tech SPAC Partners II Company Profile
Archimedes Tech SPAC Partners II (NASDAQ: ATII) is a special purpose acquisition company (SPAC) listed on the Nasdaq stock market. As a blank‑check vehicle, its primary business purpose is to identify, evaluate and complete a business combination, merger, acquisition or other similar transaction that will result in a publicly traded operating company. The company itself does not conduct an independent operating business prior to completing a qualifying transaction.
Like other SPACs, Archimedes Tech SPAC Partners II raises capital through an initial public offering and places the proceeds in a trust account while it pursues potential targets.
See Also
- Five stocks we like better than Archimedes Tech SPAC Partners II
- Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?
- The Food Delivery War Just Entered Its Final Phase
- Bath & Body Works Stock Surged Despite Falling Sales—Here’s Why
- Dick’s Sporting Goods Isn’t Done Winning Yet
Receive News & Ratings for Archimedes Tech SPAC Partners II Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Archimedes Tech SPAC Partners II and related companies with MarketBeat.com's FREE daily email newsletter.
